Journal Cover
Volume 20 No 10 (2022)
Download PDF
Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia
Dr.Ali Mohammed Shareef, Prof. Dr. Wisam Suhail Najim
Abstract
5-Reductase inhibitors (5-ARIs), also known as dihydrotestosterone (DHT) blockers, are a class
of medications with antiandrogenic effects which are used primarily in the treatment of
enlarged prostate and scalp hair loss.
Keywords
5-Reductase inhibitors, dihydrotestosterone (DHT), prostatic hyperplasia
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.